Defactinib companion diagnostic (Verastem Oncology/LabCorp) | Interleukin Related interleukin-related.com

Product Name :
Defactinib companion diagnostic (Verastem Oncology/LabCorp)

Search keywords :
Defactinib

drugId :
null

Target Vo:
Unidentified

Target Vo Short Name :
Unidentified

Moa_Name:
Undisclosed

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Laboratory Corporation Of America Holdings

Active Company_Name :

Active Indication_Name:

In Active Indication_Name:
Mesothelioma

Termination Status :
Clinical

China Termination Status :

Highest Status:
Pending

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Lutikizumab Biological Activity
Frexalimab supplier
GFP Antibody: GFP Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 27 kDa, targeting to GFP. It can be used for WB,ICC/IF,IHC-P,IP assays with tag free, in the background of .

Author: Interleukin Related

Related Posts